首页> 美国卫生研究院文献>PLoS Medicine >Intensification with dipeptidyl peptidase-4 inhibitor insulin or thiazolidinediones and risks of all-cause mortality cardiovascular diseases and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study

【2h】

Intensification with dipeptidyl peptidase-4 inhibitor insulin or thiazolidinediones and risks of all-cause mortality cardiovascular diseases and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study

机译：二甲双胍-磺脲类双重疗法患者中二肽基肽酶-4抑制剂胰岛素或噻唑烷二酮类药物的强化治疗以及全因死亡率心血管疾病和严重低血糖的风险：一项回顾性队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 PLoS Medicine
作者
Carlos K. H. Wong; Kenneth K. C. Man; Margaret Shi; Esther W. Chan; Chu Wa Ho; Emily T. Y. Tse; Ian C. K. Wong; Cindy L. K. Lam;
展开▼
作者单位

展开▼
年(卷),期 2019(16),12
年度 2019
页码 -1
总页数 16
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献

1. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study [J] . Carlos K. H. Wong, Kenneth K. C. Man, Margaret Shi, PLoS Medicine . 2019,第12期

机译：用二肽肽酶-4抑制剂，胰岛素或噻唑烷基因的增强和全甲醛 - 磺酰脲类二元治疗患者的死亡率，心血管疾病和严重低血基血症的风险：回顾性队列研究
2. Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users [J] . Diabetes care . 2020,第6期

机译：主要不良心血管事件，严重的低血糖和全导致死亡率的风险，用于广泛使用的抗血糖双重和三重疗法为2型糖尿病管理：所有丹麦用户的队列研究
3. Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia [J] . Nystrom Thomas, Bodegard Johan, Nathanson David, Diabetes research and clinical practice . 2017,第期

机译：二甲双胍单疗法后与DPP-4抑制剂相比，胰岛素的第二线开始与全因死亡，心血管事件和严重低血基血症的风险增加相关
4. Life Course Evaluation of a Plant-Centered Diet and Risk of Type 2 Diabetes, Weight Gain, Cardiovascular Diseases, All-Cause Mortality, and Markers of Chronic Kidney Disease: The Coronary Artery Risk Development in Young Adults (Cardia) Cohort [D] . Choi, Yuni. 2021

机译：生命课程评估植物中心的饮食和2型糖尿病风险，体重增加，心血管疾病，慢性肾病的全因死亡率和标志性：年轻成年人的冠状动脉风险发展（Cardia）队列
5. Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study [O] . Tzu-Lan Huang, Fei-Yuan Hsiao, Chih-Kang Chiang, 2015

机译：一项患有和不患有慢性肾脏病的糖尿病患者中与二肽基肽酶-4抑制剂相关的心血管事件的风险：一项全国队列研究
6. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study [O] . Carlos K. H. Wong, Kenneth K. C. Man, Margaret Shi, 2019

机译：用二肽肽酶-4抑制剂，胰岛素或噻唑烷基因的增强和全甲醛 - 磺酰脲类二元治疗患者的死亡率，心血管疾病和严重低血基血症的风险：回顾性队列研究

Intensification with dipeptidyl peptidase-4 inhibitor insulin or thiazolidinediones and risks of all-cause mortality cardiovascular diseases and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study

著录项

相似文献

相关主题

期刊订阅